|
1
|
Hardie DG, Carling D and Carlson M: The
AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of
the eukaryotic cell? Annu Rev Biochem. 67:821–855. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hardie DG and Alessi DR: LKB1 and AMPK and
the cancer-metabolism link - ten years after. BMC Biol. 11:362013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shackelford DB and Shaw RJ: The LKB1-AMPK
pathway: metabolism and growth control in tumour suppression. Nat
Rev Cancer. 9:563–575. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Inoki K, Ouyang H, Zhu T, Lindvall C, Wang
Y, Zhang X, Yang Q, Bennett C, Harada Y, Stankunas K, Wang CY, He
X, MacDougald OA, You M, Williams BO and Guan KL: TSC2 integrates
Wnt and energy signals via a coordinated phosphorylation by AMPK
and GSK3 to regulate cell growth. Cell. 126:955–968. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jones RG, Plas DR, Kubek S, Buzzai M, Mu
J, Xu Y, Birnbaum MJ and Thompson CB: AMP-activated protein kinase
induces a p53-dependent metabolic checkpoint. Mol Cell. 18:283–293.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hwang JT, Kim YM, Surh YJ, Baik HW, Lee
SK, Ha J and Park OJ: Selenium regulates cyclooxygenase-2 and
extracellular signal-regulated kinase signaling pathways by
activating AMP-activated protein kinase in colon cancer cells.
Cancer Res. 66:10057–10063. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mihaylova MM and Shaw RJ: The AMPK
signalling pathway coordinates cell growth, autophagy and
metabolism. Nat Cell Biol. 13:1016–1023. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sanli T, Steinberg GR, Singh G and
Tsakiridis T: AMP-activated protein kinase (AMPK) beyond
metabolism: a novel genomic stress sensor participating in the DNA
damage response pathway. Cancer Biol Ther. 15:156–169. 2014.
View Article : Google Scholar :
|
|
9
|
Kim HS, Kim MJ, Kim EJ, Yang Y, Lee MS and
Lim JS: Berberine-induced AMPK activation inhibits the metastatic
potential of melanoma cells via reduction of ERK activity and COX-2
protein expression. Biochem Pharmacol. 83:385–394. 2012. View Article : Google Scholar
|
|
10
|
Nakano A, Kato H, Watanabe T, Min KD,
Yamazaki S, Asano Y, Seguchi O, Higo S, Shintani Y, Asanuma H,
Asakura M, Minamino T, Kaibuchi K, Mochizuki N, Kitakaze M and
Takashima S: AMPK controls the speed of microtubule polymerization
and directional cell migration through CLIP-170 phosphorylation.
Nat Cell Biol. 12:583–590. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Taliaferro-Smith L, Nagalingam A, Zhong D,
Zhou W, Saxena NK and Sharma D: LKB1 is required for
adiponectin-mediated modulation of AMPK-S6K axis and inhibition of
migration and invasion of breast cancer cells. Oncogene.
28:2621–2633. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim AY, Lee CG, Lee da Y, Li H, Jeon R,
Ryu JH and Kim SG: Enhanced antioxidant effect of prenylated
polyphenols as Fyn inhibitor. Free Radic Biol Med. 53:1198–1208.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ko HH, Yen MH, Wu RR, Won SJ and Lin CN:
Cytotoxic isoprenylated flavans of Broussonetia kazinoki. J Nat
Prod. 62:164–166. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cha JY, Kim YT, Kim HS and Cho YS:
Antihyperglycemic effect of stem bark powder from paper mulberry
(Broussonetia kazinoki Sieb.) in type 2 diabetic Otsuka Long-Evans
Tokushima fatty rats. J Med Food. 11:499–505. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baek YS, Ryu YB, Curtis-Long MJ, Ha TJ,
Rengasamy R, Yang MS and Park KH: Tyrosinase inhibitory effects of
1,3-diphenylpropanes from Broussonetia kazinoki. Bioorg Med Chem.
17:35–41. 2009. View Article : Google Scholar
|
|
16
|
Lee DY, Kim DH, Lee HJ, Lee Y, Ryu KH,
Jung BI, Song YS and Ryu JH: New estrogenic compounds isolated from
Broussonetia kazinoki. Bioorg Med Chem Lett. 20:3764–3767. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ikuta J, Hano Y, Nomura T, Kawakami Y and
Sato T: Components of Broussonetia kazinoki SIEB. I Structures of
two new isoprenylated flavans and five new isoprenylated
1,3-diphenylpropane derivatives. Chem Pharm Bull. 34:1968–1979.
1986. View Article : Google Scholar
|
|
18
|
Woods A, Azzout-Marniche D, Foretz M,
Stein SC, Lemarchand P, Ferré P, Foufelle F and Carling D:
Characterization of the role of AMP-activated protein kinase in the
regulation of glucose-activated gene expression using
constitutively active and dominant negative forms of the kinase.
Mol Cell Biol. 20:6704–6711. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang W and Guan KL: AMP-activated protein
kinase and cancer. Acta Physiol. 196:55–63. 2009. View Article : Google Scholar
|
|
20
|
Jang T, Calaoagan JM, Kwon E, Samuelsson
S, Recht L and Laderoute KR: 5′-AMP-activated protein kinase
activity is elevated early during primary brain tumor development
in the rat. Int J Cancer. 128:2230–2239. 2011. View Article : Google Scholar
|
|
21
|
Yun H, Kim HS, Lee S, Kang I, Kim SS, Choe
W and Ha J: AMP kinase signaling determines whether c-Jun
N-terminal kinase promotes survival or apoptosis during glucose
deprivation. Carcinogenesis. 30:529–537. 2009. View Article : Google Scholar
|
|
22
|
Kim HS, Wannatung T, Lee S, Yang WK, Chung
SH, Lim JS, Choe W, Kang I, Kim SS and Ha J: Quercetin enhances
hypoxia-mediated apoptosis via direct inhibition of AMPK activity
in HCT116 colon cancer. Apoptosis. 17:938–949. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tseng CH: Diabetes, metformin use, and
colon cancer: a population-based cohort study in Taiwan. Eur J
Endocrinol. 167:409–416. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Din FV, Valanciute A, Houde VP, Zibrova D,
Green KA, Sakamoto K, Alessi DR and Dunlop MG: Aspirin inhibits
mTOR signaling, activates AMP-activated protein kinase, and induces
autophagy in colorectal cancer cells. Gastroenterology.
142:1504–1515.e3. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hawley SA, Fullerton MD, Ross FA,
Schertzer JD, Chevtzoff C, Walker KJ, Peggie MW, Zibrova D, Green
KA, Mustard KJ, Kemp BE, Sakamoto K, Steinberg GR and Hardie DG:
The ancient drug salicylate directly activates AMP-activated
protein kinase. Science. 336:918–922. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
O'Neill LA and Hardie DG: Metabolism of
inflammation limited by AMPK and pseudo-starvation. Nature.
493:346–355. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee YK and Park OJ: Regulation of mutual
inhibitory activities between AMPK and Akt with quercetin in MCF-7
breast cancer cells. Oncol Rep. 24:1493–1497. 2010.PubMed/NCBI
|
|
28
|
Yang X and Huang N: Berberine induces
selective apoptosis through the AMPK-mediated mitochondrial/caspase
pathway in hepatocellular carcinoma. Mol Med Rep. 8:505–510.
2013.PubMed/NCBI
|
|
29
|
Puissant A, Robert G, Fenouille N, Luciano
F, Cassuto JP, Raynaud S and Auberger P: Resveratrol promotes
autophagic cell death in chronic myelogenous leukemia cells via
JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res.
70:1042–1052. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim EK, Park JM, Lim S, Choi JW, Kim HS,
Seok H, Seo JK, Oh K, Lee DS, Kim KT, Ryu SH and Suh PG: Activation
of AMP-activated protein kinase is essential for lysophosphatidic
acid-induced cell migration in ovarian cancer cells. J Biol Chem.
286:24036–24045. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Frigo DE, Howe MK, Wittmann BM, Brunner
AM, Cushman I, Wang Q, Brown M, Means AR and McDonnell DP: CaM
kinase kinase β-mediated activation of the growth regulatory kinase
AMPK is required for androgen-dependent migration of prostate
cancer cells. Cancer Res. 71:528–537. 2011. View Article : Google Scholar :
|
|
32
|
Ouchi N, Kobayashi H, Kihara S, Kumada M,
Sato K, Inoue T, Funahashi T and Walsh K: Adiponectin stimulates
angiogenesis by promoting cross-talk between AMP-activated protein
kinase and Akt signaling in endothelial cells. J Biol Chem.
279:1304–1309. 2004. View Article : Google Scholar
|
|
33
|
Martinelli R, Gegg M, Longbottom R,
Adamson P, Turowski P and Greenwood J: ICAM-1-mediated endothelial
nitric oxide synthase activation via calcium and AMP-activated
protein kinase is required for transendothelial lymphocyte
migration. Mol Biol Cell. 20:995–1005. 2009. View Article : Google Scholar :
|
|
34
|
Park JJ, Seo SM, Kim EJ, Lee YJ, Ko YG, Ha
J and Lee M: Berberine inhibits human colon cancer cell migration
via AMP-activated protein kinase-mediated downregulation of
integrin β1 signaling. Biochem Biophys Res Commun. 426:461–467.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peyton KJ, Yu Y, Yates B, Shebib AR, Liu
XM, Wang H and Durante W: Compound C inhibits vascular smooth
muscle cell proliferation and migration in an AMP-activated protein
kinase-independent fashion. J Pharmacol Exp Ther. 338:476–484.
2011. View Article : Google Scholar : PubMed/NCBI
|
